(Silver Spring) 16, no. 1 (2008): 29–33.
29. Soares, M. J., et al. “The Acute Effects of Olive Oil V. Cream on Postprandial Thermogenesis and Substrate Oxidation in Postmenopausal Women.” British Journal of Nutrition 91, no. 2 (2004): 245–252.
30. Piers, L. S., et al. “Substitution of Saturated with Monounsaturated Fat in a 4-Week Diet Affects Body Weight and Composition of Overweight and Obese Men.” British Journal of Nutrition 90, no. 3 (2003): 717–727; Piers, L. S., et al. “The Influence of the Type of Dietary Fat on Postprandial Fat Oxidation Rates: Monounsaturated (Olive Oil) Vs Saturated Fat (Cream).” International Journal of Obesity and Related Metabolic Disorders 26, no. 6 (2002): 814–821; Thomsen, C., et al. “Differential Effects of Saturated and Monounsaturated Fats on Postprandial Lipemia and GlucagonLike Peptide 1 Responses in Patients with Type 2 Diabetes.” American Journal of Clinical Nutrition 77, no. 3 (2003): 605–611; Thomsen, C., et al. “Differential Effects of Saturated and Monounsaturated Fatty Acids on Postprandial Lipemia and Incretin Responses in Healthy Subjects.” American Journal of Clinical Nutrition 69, no. 6 (1999): 1135–1143.
31. Feranil, A. B., et al. “Coconut Oil Is Associated with a Beneficial Lipid Profile in Pre-Menopausal Women in the Philippines.” Asia Pacific Journal of Clinical Nutrition 20, no. 2 (2011): 190–195.
32. Babu, A. S., et al. “Virgin Coconut Oil and Its Potential Cardioprotective Effects.” Postgrad Medicine 126, no. 7 (2014): 76–83.
33. St-Onge, M. P., et al. “Medium Chain Triglyceride Oil Consumption as Part of a Weight Loss Diet Does Not Lead to an Adverse Metabolic Profile When Compared to Olive Oil.” The Journal of the American College of Nutrition 27, no. 5 (2008): 547–552.
34. Nosaka, N., et al. “Effects of Margarine Containing Medium-Chain Triacylglycerols on Body Fat Reduction in Humans.” Journal of Atherosclerosis and Thrombosis 10, no. 5 (2003): 290–298.
35. Stubbs, R. J., and C. G. Harbron. “Covert Manipulation of the Ratio of Medium– to Long-Chain Triglycerides in Isoenergetically Dense Diets: Effect on Food Intake in Ad Libitum Feeding Men.” International Journal of Obesity and Related Metabolic Disorders 20, no. 5 (1996): 435–444.
36. Van Wymelbeke, V., et al. “Influence of MediumChain and Long-Chain Triacylglycerols on the Control of Food Intake in Men.” American Journal of Clinical Nutrition 68, no. 2 (1998): 226–234.
37. Scalfi, L., A. Coltorti, and F. Contaldo. “Postprandial Thermogenesis in Lean and Obese Subjects After Meals Supplemented with Medium-Chain and Long-Chain Triglycerides.” American Journal of Clinical Nutrition 53, no. 5 (1991): 1130–1133.
38. Heid, M. “You Asked: Is Coconut Oil Healthy?” Time, April 26, 2017, открыто по адресу www.time.com/4755761/coconut-oil-healthy/.
39. St-Onge, M. P., and P. J. Jones. “Physiological Effects of Medium-Chain Triglycerides: Potential Agents in the Prevention of Obesity.” The Journal of Nutrition 132, no. 3 (2002): 329–332.
40. Lindeberg, S., and B. Lundh. “Apparent Absence of Stroke and Ischaemic Heart Disease in a Traditional Melanesian Island: A Clinical Study in Kitava.” Journal of Internal Medicine 233, no. 3 (1993): 269–275.
41. Stanhope, J. M., and I. A. Prior. “The Tokelau Island Migrant Study: Prevalence and Incidence of Diabetes Mellitus.” New Zealand Medical Journal 92, no. 673 (1980): 417–421.
42. de Oliveira Otto, M. C., et al. “Serial Measures of Circulating Biomarkers of Dairy Fat and Total and Cause-Specific Mortality in Older Adults: The Cardiovascular Health Study.” American Journal of Clinical Nutrition 108, no. 3 (2018): 476–484.
43. Yakoob, M. Y., et al. “Circulating Biomarkers of Dairy Fat and Risk of Incident Stroke in U.S. Men and Women in 2 Large Prospective Cohorts.” American Journal of Clinical Nutrition 100, no. 6 (2014): 1437–1447.
44. University of Texas Health Science Center at Houston. “New Research Could Banish Guilty Feeling for Consuming Whole Dairy Products.” Сайт Science Daily, открыто по адресу www.sciencedaily.com/releases/2018/07/180711182735.htm.
45. Aune, D., et al. “Dairy Products and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies.” American Journal of Clinical Nutrition 98, no. 4 (2013): 1066–1083.
46. Astrup, A. “A Changing View on Saturated Fatty Acids and Dairy: From Enemy to Friend.” American Journal of Clinical Nutrition 100, no. 6 (2014): 1407–1408.
47. Freeman, A. M., et al. “Trending Cardiovascular Nutrition Controversies.” Journal of the American College of Cardiology 69, no. 9 (2017): 1172–1187.
48. Eckel, R. H., et al. “2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Journal of the American College of Cardiology 63, no. 25 Pt B (2014): 2960–2984.
49. Covas, M. I., et al. “The Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors: A Randomized Trial.” Annals of Internal Medicine 145, no. 5 (2006): 333–341.
50. Wiseman, S. A., et al. “Dietary Non-Tocopherol Antioxidants Present in Extra Virgin Olive Oil Increase the Resistance of Low Density Lipoproteins to Oxidation in Rabbits.” Atherosclerosis 120, no. 1–2 (1996): 15–23; Caruso, D., et al. “Effect of Virgin Olive Oil Phenolic Compounds on In Vitro Oxidation of Human Low Density Lipoproteins.” Nutrition, Metabolism and Cardiovascular Diseases 9, no. 3 (1999): 102–107; Coni, E., et al. “Protective Effect of Oleuropein, an Olive Oil Biophenol, on Low Density Lipoprotein Oxidizability in Rabbits.” Lipids 35, no. 1 (2000): 45–54.
51. Aviram, M., and K. Eias. “Dietary Olive Oil Reduces Low-Density Lipoprotein Uptake by Macrophages and Decreases the Susceptibility of the Lipoprotein to Undergo Lipid Peroxidation.” Annals of Nutrition and Metabolism 37, no. 2 (1993): 75–84.
52. Bogani, P., et al. “Postprandial Anti-Inflammatory and Antioxidant Effects of Extra Virgin Olive Oil.” Atherosclerosis 190, no. 1 (2007): 181–186.
53. Pacheco, Y. M., et al. “Minor Compounds of Olive Oil Have Postprandial Anti-Inflammatory Effects.” British Journal of Nutrition 98, no. 2 (2007): 260–263.
54. Fabiani, R., et al. “Oxidative DNA Damage Is Prevented by Extracts of Olive Oil, Hydroxytyrosol, and Other Olive Phenolic Compounds in Human Blood Mononuclear Cells and HL60 Cells.” The Journal of Nutrition 138, no. 8 (2008): 1411–1416.
55. Moreno-Luna, R., et al. “Olive Oil Polyphenols Decrease Blood Pressure and Improve Endothelial Function in Young Women with Mild Hypertension.” American Journal of Hypertension 25, no. 12 (2012): 1299–1304.
56. DiNicolantonio, J. J., et al. “Omega-3s and Cardiovascular Health.” Ochsner Journal 14, no. 3 (2014): 399–412.
57. DiNicolantonio, J. J., P. Meier, and J. H. O’Keefe. “Omega-3 Polyunsaturated Fatty Acids for the Prevention of Cardiovascular Disease: Do Formulation, Dosage & Comparator Matter?” Missouri Medicine 110, no. 6 (2013): 495–498.
58. Hulbert, A. J., and P. L. Else. “Membranes as Possible Pacemakers of Metabolism.” Journal of Theoretical Biology 199, no. 3 (1999): 257–274; Smith, G. I., et al. “Dietary Omega-3 Fatty Acid Supplementation Increases the Rate of Muscle Protein Synthesis in Older Adults: A Randomized Controlled Trial.” American Journal of Clinical Nutrition 93, no. 2 (2011): 402–412; Whitehouse, A. S., et al. “Mechanism of Attenuation of Skeletal Muscle Protein Catabolism in Cancer Cachexia by Eicosapentaenoic Acid.” Cancer Research 61, no. 9 (2001): 3604–3609.
59. См. примечание 29 выше.
60. Deutsch, L. “Evaluation of the Effect of Neptune Krill Oil on Chronic Inflammation and Arthritic Symptoms.” The Journal of the American College of Nutrition 26, no. 1 (2007): 39–48.
61. Sampalis, F., et al. “Evaluation of the Effects of Neptune Krill Oil in the Management of Premenstrual Syndrome and Dysmenorrhea.” Alternative Medicine Review 8, no. 2 (2003): 171–179.
62. Bunea, R., K. El Farrah, and L. Deutsch. “Evaluation of the Effects of Neptune Krill Oil on the Clinical Course of Hyperlipidemia.” Alternative Medicine Review 9, no. 4 (2004): 420–428.
63. Bower, B. “Human Ancestors Had Taste for Meat, Brains.” Science News, May 3, 2013, открыто по адресу www.sciencenews.org/article/human-ancestors-had-taste-meat-brains.
64. Cordain, L., et al. “Fatty Acid Analysis of Wild Ruminant Tissues: Evolutionary Implications for Reducing Diet-Related Chronic Disease.” European Journal of Clinical Nutrition 56, no. 3 (2002): 181–191.
65. Nguyen, L. N., et al. “Mfsd2a Is a Transporter for the Essential Omega-3 Fatty Acid Docosahexaenoic Acid.” Nature 509, no. 7501 (2014): 503–506; Alakbarzade, V., et al. “A Partially Inactivating Mutation in the Sodium-Dependent Lysophosphatidylcholine Transporter MFSD2A Causes a Non-Lethal Microcephaly Syndrome.” Nature Genetics 47, no. 7 (2015): 814–817; Guemez-Gamboa, A., et al. “Inactivating Mutations in MFSD2A, Required for Omega-3 Fatty Acid Transport in Brain, Cause a Lethal Microcephaly Syndrome.” Nature Genetics 47, no. 7 (2015): 809–813.
66. Bunea, R., K. El Farrah, and L. Deutsch. “Evaluation of the Effects of Neptune Krill Oil on the Clinical Course of Hyperlipidemia.” Alternative Medicine Review 9, no. 4 (2004): 420–428; “Neptune Krill Oil.” Открыто по адресу https://nutrisan-export.com/wp-content/uploads/2016/03/productinfoNKO.pdf; Batetta, B., et al. “Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats.”